GSK grants license for Ebola vaccines to Sabin Vaccine Institute

This article was originally published here

The agreements between GSK and Sabin in this regard are for advancing the development of the prophylactic candidate Ebola vaccines against the Ebola Zaire, Ebola Sudan and the

The post GSK grants license for Ebola vaccines to Sabin Vaccine Institute appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply